Bids Are Invited For Medicines In The Form Of Full Delivery To Hpm. I Know 1250.01.0001712/2026-74

Fluorescein - Active Ingredient: Sodium Fluorescein; Concentration/Dosage: 10 Mg/Ml (1%); Pharmaceutical Form: Ophthalmic Solution; Presentation: Bottle 3, Cabozantinib - Active Ingredient: Cabozantinib; Concentration/Dosage: 20 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Component: .;, Methylcellulose - Active Ingredient: Methylcellulose; Concentration/Dosage: 20 Mg/Ml (2%); Pharmaceutical Form: Ophthalmic Solution; Presentation: 10 Ml Bottle, Vitamin And/Or Mineral Supplement - Composition (1): A + B1 + B2 + B3 + B5 + B6+ B8 + C + D + E; Composition (2): .; Pharmaceutical Form: Oral Solution; A, Clonidine - Active Ingredient: Clonidine, Hydrochloride; Concentration/Dosage: 0.1 Mg; Pharmaceutical Form: Tablet; Presentation: .; Component: .;, 16/04/2026 - 14:00:39, , Notice, Iodized Poppy Oil - Active Ingredient: Iodized Poppy Oil; Concentration/Dosage: 480 Mg/Ml Iodine; Pharmaceutical Form: Injectable Solution; Apres, Neostigmine - Active Ingredient: Neostigmine, Methylsulfate; Concentration/Dosage: 0.5 Mg/Ml; Pharmaceutical Form: Injectable Solution; Presentation: Ampoule, Ferric Oxide Saccharate - Active Ingredient: Ferric Oxide Saccharate; Concentration/Dosage: 20 Mg/Ml; Pharmaceutical Form: Injectable Solution; Apresen, Etoposide - Active Ingredient: Etoposide; Concentration/Dosage: 100 Mg (20 Mg/Ml); Pharmaceutical Form: Injectable Solution; Presentation: Ampoule 5, Ipratropium Bromide - Active Ingredient: Ipratropium, Bromide; Concentration/Dosage: 20 Mcg/Dose; Pharmaceutical Form: Aerosol Solution; Presentation: Fr, Potassium Phosphate - Active Ingredient: Potassium Phosphate; Concentration/Dosage: 2 Meq/L; Pharmaceutical Form: Injectable Solution; Presentation: Ampoule, Glycerol - Active Ingredient: Glycerol; Concentration/Dosage: 2.2 To 2.7 G; Pharmaceutical Form: Adult Suppository; Presentation: .; Component: .;, Cisplatin - Active Ingredient: Cisplatin; Concentration/Dosage: 50 Mg; Pharmaceutical Form: Injectable Solution; Presentation: 50 Ml Ampoule Bottle; Compon, Dexamethasone - Active Ingredient: Dexamethasone; Concentration/Dosage: 1 Mg/Ml; Pharmaceutical Form: Ophthalmic Suspension; Presentation: 5 Ml Bottle; Compon, Durvalumab Active Ingredient: Durvalumab; Concentration/Dosage: 50 Mg/Ml; Pharmaceutical Form: Injectable Solution; Presentation: Ampoule Bottle 2.4 Ml; Co, Formula Or Manipulated Association - Active Ingredient: Neotutocaine; Concentration/Dosage: 20 Mg/Ml (2%); Pharmaceutical Form: Solution; Presentation: Bottle